SELLAS Life Sciences (SLS) Change in Accured Expenses (2010 - 2026)

SELLAS Life Sciences (SLS) reported Change in Accured Expenses of -$1.3 million for Q1 2026, up 56.34% year-over-year from -$808502.0 in Q1 2025, and down 331.93% on a QoQ basis from $545000.0 in Q4 2025.

SELLAS Life Sciences (SLS) has 17 years of Change in Accured Expenses data on file, last reported at -$1.3 million in Q1 2026.

  • Quarterly Change in Accured Expenses rose 56.34% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$310000.0 (up 92.32% YoY) and the FY2025 annual result came in at -$1.9 million, up 11.13% from the prior year.
  • Change in Accured Expenses retreated to -$1.3 million in Q1 2026 per SLS's latest filing, from $545000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.7 million in Q4 2022 and bottomed at -$2.9 million in Q1 2025.
  • The 5-year median for Change in Accured Expenses is $196000.0 (2023), against an average of -$17294.1.
  • The widest annual swing landed in 2022, when Change in Accured Expenses surged 2713.11%; it then sank 631.63% in 2024.
  • Tracing SLS's Change in Accured Expenses over 5 years: stood at $1.7 million in 2022, then tumbled by 53.03% to $806000.0 in 2023, then sank by 102.98% to -$24000.0 in 2024, then soared by 2370.83% to $545000.0 in 2025, then sank by 331.93% to -$1.3 million in 2026.
  • Per Business Quant, the three latest SLS Change in Accured Expenses figures stand at -$1.3 million (Q1 2026), $545000.0 (Q4 2025), and $897000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 931,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -176.03 Mn
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - -1.26 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.26 Mn
Mar 31, 2026 -1.26 Mn
Dec 31, 2025 545,000.00
Dec 31, 2025 545,000.00
Sep 30, 2025 897,000.00
Sep 30, 2025 897,000.00
Jun 30, 2025 -488,000.00
Jun 30, 2025 -488,000.00
Mar 31, 2025 -2.90 Mn
Mar 31, 2025 -2.90 Mn
Dec 31, 2024 -24,000.00
Dec 31, 2024 -24,000.00
Sep 30, 2024 307,000.00
Sep 30, 2024 307,000.00
Jun 30, 2024 -1.43 Mn
Jun 30, 2024 -1.43 Mn
Mar 31, 2024 -1.04 Mn
Mar 31, 2024 -1.04 Mn
Dec 31, 2023 806,000.00
Dec 31, 2023 806,000.00
Sep 30, 2023 689,000.00
Sep 30, 2023 689,000.00
Jun 30, 2023 -242,000.00
Jun 30, 2023 -242,000.00
Mar 31, 2023 196,000.00
Mar 31, 2023 196,000.00
Dec 31, 2022 1.72 Mn
Dec 31, 2022 1.72 Mn
Sep 30, 2022 1.56 Mn
Sep 30, 2022 1.56 Mn
Jun 30, 2022 215,000.00
Jun 30, 2022 215,000.00
Mar 31, 2022 151,000.00
Mar 31, 2022 151,000.00
Dec 31, 2021 61,000.00
Dec 31, 2021 61,000.00
Sep 30, 2021 802,000.00
Sep 30, 2021 802,000.00
Jun 30, 2021 -770,000.00
Jun 30, 2021 -770,000.00
Mar 31, 2021 634,000.00
Mar 31, 2021 634,000.00
Dec 31, 2020 -391,000.00
Dec 31, 2020 -391,000.00
Sep 30, 2020 495,000.00
Sep 30, 2020 495,000.00
Jun 30, 2020 921,000.00
Jun 30, 2020 921,000.00
Mar 31, 2020 -283,000.00
Mar 31, 2020 -283,000.00
Dec 31, 2019 -333,000.00
Dec 31, 2019 -333,000.00
Sep 30, 2019 323,000.00
Sep 30, 2019 323,000.00
Jun 30, 2019 374,000.00
Jun 30, 2019 374,000.00
Mar 31, 2019 -1.41 Mn
Mar 31, 2019 -1.41 Mn
Dec 31, 2018 -2.46 Mn
Dec 31, 2018 -2.46 Mn
Sep 30, 2018 683,000.00
Sep 30, 2018 683,000.00
Jun 30, 2018 -1.70 Mn
Jun 30, 2018 -1.70 Mn
Mar 31, 2018 1.20 Mn
Mar 31, 2018 1.20 Mn
Dec 31, 2017 -2.46 Mn
Dec 31, 2017 -2.46 Mn
Sep 30, 2017 85,000.00
Sep 30, 2017 85,000.00
Jun 30, 2017 3.84 Mn
Jun 30, 2017 3.84 Mn
Mar 31, 2017 -3.84 Mn
Mar 31, 2017 -3.84 Mn
Dec 31, 2016 3.30 Mn
Dec 31, 2016 3.30 Mn
Sep 30, 2016 -884,000.00
Sep 30, 2016 -884,000.00
Jun 30, 2016 661,000.00
Jun 30, 2016 661,000.00
Mar 31, 2016 -1.25 Mn
Mar 31, 2016 -1.25 Mn
Dec 31, 2015 -2.04 Mn
Dec 31, 2015 -2.04 Mn
Sep 30, 2015 -176,000.00
Sep 30, 2015 -176,000.00
Jun 30, 2015 505,000.00
Jun 30, 2015 505,000.00
Mar 31, 2015 -1.89 Mn
Mar 31, 2015 -1.89 Mn
Dec 31, 2014 1.58 Mn
Dec 31, 2014 1.58 Mn
Sep 30, 2014 -657,000.00
Sep 30, 2014 -657,000.00
Jun 30, 2014 2.10 Mn
Jun 30, 2014 2.10 Mn
Mar 31, 2014 1.03 Mn
Mar 31, 2014 1.03 Mn
Dec 31, 2013 836,000.00
Dec 31, 2013 836,000.00
Sep 30, 2013 481,000.00
Sep 30, 2013 481,000.00
Jun 30, 2013 1.05 Mn
Jun 30, 2013 1.05 Mn
Mar 31, 2013 440,000.00
Mar 31, 2013 440,000.00
Dec 31, 2012 16,000.00
Dec 31, 2012 16,000.00
Sep 30, 2012 534,000.00
Sep 30, 2012 534,000.00
Jun 30, 2012 -247,000.00
Jun 30, 2012 -247,000.00
Mar 31, 2012 -452,000.00
Mar 31, 2012 -452,000.00
Dec 31, 2011 407,000.00
Dec 31, 2011 407,000.00
Sep 30, 2011 412,000.00
Sep 30, 2011 412,000.00
Jun 30, 2011 405,000.00
Jun 30, 2011 405,000.00
Mar 31, 2011 930,000.00
Mar 31, 2011 930,000.00
Dec 31, 2010 -63,000.00
Dec 31, 2010 -63,000.00
Sep 30, 2010 -27,000.00
Sep 30, 2010 -27,000.00